Indivior Pharmaceuticals (INDV) Inventory (2021 - 2026)

Indivior Pharmaceuticals' Inventory history runs 6 years deep, the most recent figure standing at $152.0 million for Q1 2026.

• On a quarterly basis, Inventory fell 6.75% year-over-year to $152.0 million in Q1 2026; TTM through Mar 2026 was $152.0 million, a 6.75% decrease from a year earlier, with the FY2025 full-year figure at $153.0 million, down 8.38% from the prior year.
• Inventory declined to $152.0 million in Q1 2026 per INDV's latest filing, from $153.0 million in the prior quarter.
• Across five years, Inventory topped out at $167.0 million in Q4 2024 and bottomed at $114.0 million in Q4 2022.
• The 5-year median for Inventory is $152.5 million (2025), against an average of $147.4 million.
• Across the five-year window, Inventory jumped 32.54% in 2024 and declined 8.38% in 2025, its largest moves.
• Year by year, Inventory stood at $114.0 million in 2022, then climbed by 10.53% to $126.0 million in 2023, then soared by 32.54% to $167.0 million in 2024, then retreated by 8.38% to $153.0 million in 2025, then decreased by 0.65% to $152.0 million in 2026.
• Per Business Quant, the three latest INDV Inventory figures stand at $152.0 million (Q1 2026), $153.0 million (Q4 2025), and $155.0 million (Q3 2025).